OPKO Health (OPK) Competitors

OPKO Health (NASDAQ:OPK) and Ligand Pharmaceuticals (NASDAQ:LGND) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

Which has better valuation & earnings, OPK or LGND?

Ligand Pharmaceuticals has lower revenue, but higher earnings than OPKO Health. Ligand Pharmaceuticals is trading at a lower price-to-earnings ratio than OPKO Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OPKO Health	$713.10M	1.57	-$53.22M	-$0.25	-5.64
Ligand Pharmaceuticals	$167.13M	18.66	-$4.03M	-$4.00	-39.77

Do analysts prefer OPK or LGND?

OPKO Health currently has a consensus target price of $2.75, indicating a potential upside of 95.04%. Ligand Pharmaceuticals has a consensus target price of $157.00, indicating a potential downside of 1.31%. Given OPKO Health's higher possible upside, analysts clearly believe OPKO Health is more favorable than Ligand Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OPKO Health	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.83
Ligand Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is OPK or LGND more profitable?

OPKO Health has a net margin of -26.68% compared to Ligand Pharmaceuticals' net margin of -40.44%. Ligand Pharmaceuticals' return on equity of -9.21% beat OPKO Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OPKO Health	-26.68%	-13.17%	-8.28%
Ligand Pharmaceuticals	-40.44%	-9.21%	-8.09%

Does the media prefer OPK or LGND?

In the previous week, Ligand Pharmaceuticals had 8 more articles in the media than OPKO Health. MarketBeat recorded 10 mentions for Ligand Pharmaceuticals and 2 mentions for OPKO Health. OPKO Health's average media sentiment score of 1.68 beat Ligand Pharmaceuticals' score of 1.32 indicating that OPKO Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OPKO Health	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Ligand Pharmaceuticals	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, OPK or LGND?

OPKO Health has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, Ligand Pharmaceuticals has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in OPK or LGND?

64.6% of OPKO Health shares are held by institutional investors. Comparatively, 91.3% of Ligand Pharmaceuticals shares are held by institutional investors. 49.7% of OPKO Health shares are held by insiders. Comparatively, 7.0% of Ligand Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

OPKO Health beats Ligand Pharmaceuticals on 9 of the 17 factors compared between the two stocks.